Physician profile
William A Yoder
NPI 1770819567
$4,162.05
in general payments reported to CMS, 2019-2025
30 companies · $637 in 2025
The $637 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,334 · 2020: $79.41 · 2021: $123 · 2022: $233 · 2023: $322 · 2024: $434 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,381.84 | 2019 | |
| Great Lakes Orthopedics | $478.30 | 2019 | |
| Smith+Nephew, INC. | $453.55 | 2019-2025 | Grafix Pl, Oasis, Pico |
| Ani Pharmaceuticals, INC. | $296.82 | 2024-2025 | Purified Cortrophin Gel |
| Integra Lifesciences Corporation | $241.21 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Paratek Pharmaceuticals, INC. | $128.82 | 2020-2025 | Nuzyra |
| Linvatec Corporation | $124.97 | 2025 | Biobrace 23mm |
| Next Science LLC | $108.18 | 2022-2023 | Xperience, Surgx, Blastx |
| Kerecis Limited | $106.82 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Averitas Pharma INC. | $96.86 | 2023-2025 | Qutenza |
| Arteriocyte Medical Systems, INC. | $84.47 | 2019 | |
| Melinta Therapeutics, LLC | $67.20 | 2019 | |
| Aroa Biosurgery Incorporated | $60.18 | 2023 | |
| Stryker Corporation | $57.10 | 2022-2023 | Prostep |
| Mimedx Group, INC. | $54.46 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $52.27 | 2025 | |
| Merck Sharp & Dohme LLC | $51.41 | 2019 | |
| Zimmer Biomet Holdings, INC. | $49.97 | 2020-2021 | |
| Organogenesis INC. | $48.91 | 2021-2022 | |
| Orthofix Medical, INC. | $46.58 | 2022-2023 | Physio-Stim |
| Nevro Corp. | $43.01 | 2022-2024 | Senza |
| Treace Medical Concepts, INC. | $23.38 | 2024 | |
| Acell, INC. | $18.50 | 2019 | |
| Celularity INC. | $16.00 | 2019 | |
| Avita Medical Americas, LLC | $15.33 | 2025 | Cohealyx, Permeaderm, Recell |
| Grt US Holding, INC. | $14.17 | 2022 | |
| Zyla Life Sciences, INC. | $13.65 | 2019 | |
| Arthrosurface Incorporated | $12.60 | 2019 | |
| Ermi LLC | $9.43 | 2021 | |
| Dynasplint Systems INC. | $6.06 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.